Conférences - Pharmacologie et développement des médicaments

Our 3 days comprehensive workshop on “Chem-informatics & Drug Discovery” aims at providing systematic Hands-on-Training on using advanced Chem-informatics & Drug Discovery application/tools. This workshop had been conceptualized by eminent scientist having substantial experience in the field of modeling & simulations.

Tél.: [7798668315];     Email.: info@rasalsi.com

Topics to be covered in workshop: Analyzing chemical fingerprint, Generating Knowledge from structure and different chemical databases, Using various chemical structure drawing and visualization tools, Digitizing your chemical Data, Structure and ligand based vHTS Screening, Pharmacophore based Virtual Screening of compounds, Docking Studies and Drug Likeness, Hands on training on commercial software’s of Drug discovery, Interaction and guidance from eminent scientist from Industry & Academics, Training from industry experts from CADD domain.

Biotechnologie,    Génomique et bio-informatique

Federal State Institution “State Institute of Drugs and Good Practises” and the Ministry of Industry and Trade of Russian Federation

Experts from the pharmaceutical industry, representatives of government agencies, leaders of professional associations will meet on the IV all-Russian GMP conference (GMP/Good Manufacturing Practice/ system of rules and standards of production) to discuss topical issues of the Russian pharmaceutical market.

GMP/Good Manufacturing Practice/ system of rules and standards of production

American Statistical Association

Statistique, Théorie des jeux,    Législation en médecine et pharmacologie

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Oxford Global are proud to present the 17th Annual Pharmaceutical IT & Data Congress, 25 - 26 September 2019, London, UK. Over 450 attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions.

Tél.: [+44 (0)1865 248455];     Email.: a.saez@oxfordglobal.co.uk

R&D IT, Enterprise Architecture, R&D Information, Data Analytics, Enterprise Technologies, Cloud Computing, Translational Sciences, Digital Solutions, Research IT, Real-World Data, Digital Health, Real-World Evidence, Translational Informatics, Data Infrastructure, Data Management, Data Analysis, Bioinformatics, Data Standardisation, Data Storage, External Innovation, Data Archiving, Data Operations, Data Governance, Big Data, IT Strategy, Virtualisation, Blockchain, Data Validation, Data Visualisation, Knowledge Management

Tél.: [02078276000];     Email.: ssapal@smi-online.co.uk

Biosimilar, Biobetters, biologic, generic drug, immunogenicity, innovator, interchangeability, pharmacist, doctors, dosage, legislation, commercialising biosimilars, patent protection

Législation en médecine et pharmacologie,    Médecine translationnelle, essais cliniques

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry.

Tél.: [+44 2036120886];     Email.: kavitha@virtueinsight.co.in

Pharmacovigilance, DrugSafety, ProductSafety, DrugDevelopment, ClinicalSafety, patientsafety, RiskManagement, regulatoryaffairs

SMi Group are pleased to announce the Inaugural Pharmaceutical Cleanroom Technology Europe Conference, taking place on the 9th and 10th October 2019 in London, UK. As the first event in Europe that focuses on cleanroom technology in the pharmaceutical industry, the conference will serve to bridge that gap between the two areas while simultaneously providing a unique selling point.

Tél.: [02078276000];     Email.: ssapal@smi-online.co.uk

Annex 1, ISO 14644, GMP, RMM, Rapid Micro Methods, Contamination recovery rates, Cleanroom, Mycoplasma, Data Integrity, Environmental monitoring, HVAC system, Contamination Control, RABS, restricted-access barrier system

Lyotalk is USA's largest annual conference on Lyophilization/Freeze Drying. Lyotalk attracts gathering experts from pharma, biotech and Academia from USA and rest of the world for 2 days of learning of latest technology and networking, discovering new opportunities and partnerships.

Tél.: [8433632006];     Email.: marketing@biotrains.com

CURRENT REGULATORY CONSIDERATIONS, FORMULATION STRATEGIES & DESIGNS, PAT TOOLS TO MONITOR THE LYOPHILISATION PROCESS, EFFICIENT MANUFACTURING SYSTEMS, BULK FREEZE DRYING, FREEZE DRYING OF PROTEINS, LATEST TECHNOLOGY & DEVELOPMENTS, PROCESS CONTROLS - VACCUM & SHELF TEMPERATURE, HEADSPACE MOISTURE ANALYSIS,

Biotechnologie,    Biotechnologie

This 3 day masterclass has been specially designed by the course directors to provide an update on the latest developments in paediatric pharmacy and aims to discuss best practice methods in the safe use of medicines in children. The programme has been created to ensure that delegates gain the most from their time visiting Guy’s and St Thomas’ NHS Foundation Trust.

Tél.: [+ 44 (0)207 188 7352];     Email.: events@gstt.nhs.uk

paediatric pharmacy, pharmacology, paediatric pharmaceutical care, children's medicine

Welcome to Global Conference on Virology & Vaccines is going to be scheduled for October 14-16, 2019 in Osaka, Japan. This exciting symposium will provide you with an overview of significant areas in Virology & Vaccines research, varying from Viral Infections to T cell Activation & Gene editing. These subject areas will form the core of the scientific program that is initiated by overviews of Virus interactions with the host and is closed with an outlook on the future.

Tél.: [+0034518889990];     Email.: secretary.osaka@virologycongress.com

Immunology, Vaccines, Microbiology

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Be able to decide on the best deal type for products in R&D – Know what to include in CDAs, MTAs and term sheets – Learn how to prepare product information and how to find potential partners – Know how to calculate the value of your product and optimise the deal structure.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

SMi Group are proud to announce the 9th Annual Orphan Drugs and Rare Diseases Conference, taking place on the 15th and 16th October 2019 in London, UK. The orphan drug market is continuously growing and is expected to reach $176 billion by 2020, with a CGR of 10.5% just for orphan drugs – this is twice the growth rate of the overall prescription drug market (5.3% CGR from 2014-2020). By 2020, orphan drugs are set to account for 19% of global prescription sales.

Tél.: [02078276000];     Email.: ssapal@smi-online.co.uk

Patient recruitment, Reimbursement, Patient Groups, Orphan Drugs, Gene therapy, Orphan Drugs, Rare Diseases, Gene Therapy, Clinical Trials

Biotechnologie,    Génie biomédical

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

United Scientific Group (A Non-Profit Organization) hosted three events still now on Cancer Research and Targeted Therapy twice in USA and once in UK. Having a total of 200 participants and their positive notes we are happy to announce our next event the fourth edition of Cancer Research & Drug Development at the largest independent city Baltimore USA this October 21-23, 2019.

Tél.: [+1-408-426-4832];     Email.: cancer.therapy@uniscigroup.org

Cancer Metastasis, Cancer Resistance, Cancer Microenvironment, Novel Therapeutics target in Cancer, Cancer drug development, Cancer Immunotherapy, Cancer Targeted Therapy, Cancer Nanomedicine, Cancer Radiation Therapy, Cancer Genetics, Breast Cancer, Uterine Cancer, Lung Cancer, Hematological Cancer, Sarcoma.

It is our pleasure to warmly invite you to participate in the upcoming International Congress on Clinical Trials in Cannabis (CT-Cann2019), which will take place on 24-25 October 2019 in London, UK. The endocannabinoid system is involved in numerous physiological and behavioral processes and, as such, has potential therapeutic implications relevant to many human diseases. Accordingly, in recent years there has been intense interest in the study and application of cannabinoid therapy in almost all areas of clinical medicine. However, while cannabinoids undoubtedly present us with many promising prospects and opportunities, translational and clinical cannabinoid research is, for the most part, still in its infancy. CT-Cann2019 is an international meeting that will bring together leading researchers, clinicians, industry professionals and other related experts to discuss ways of improving current research strategies in this rapidly evolving field. We will touch, among other things, on basic and clinical methodologies, regulatory and legal issues, pharmacological considerations, and technological advancements related to cannabinoid administration. CT-Cann2019 will thus inform participants of the latest evidence and concepts regarding cannabinoid therapy, promote an exchange of ideas and practices in clinical trials on cannabis, and will undoubtedly spark many engaging and lively debates.

Tél.: [+442030514032 ext 525];     Email.: Ilana@bioevents-congress.com

Phytocannabinoid study – strains, chemovars, entourage and molecules, Pharamacokinetics and pharmacodynamics of cannabinoids, Prediction of response to cannabinoid treatment, Clinical trials targeting Pain, GI Disorders, Palliative Care, Psychiatry and Neurological disorders, New designs for cannabis clinical trials (including pragmatic trials and n=1), Clinical Registries, Observational / Epidemiological studies: findings, interpretations, plans, Phase 2/3/4 study findings and designs (including special populations), Meta- and composite- analyses: findings and methodology, Regulatory, licensing, and development programme issues and plans, Cannabinoid trial best conduct including GCP and site training, Assessing safety of cannabinoid medications, Innovative route of administration (ROA) and titration technologies, Big data and cannabis, Cannabinoids and Opioids

The 6th Annual European Pharma Market Research Conference (October 29-30, 2019, Basel) is the best and largest industry assembly of market research executives in pharma, biotech, medical devices, and diagnostics. This prestigious event brings together the industry’s top thought leaders and creates an environment of new ideas, relationships and perspectives. This event is unlike any other conference in Europe. It’s immersive, interactive and focused on giving you and your colleagues the methodologies to deal with the new challenges and opportunities facing the industry.

Tél.: [+1-212-228-7974];     Email.: info@pharmamarketresearchconference.com.

Join over 150 delegates from from internationally renowned academic institutions global pharmaceutical organisations and leading biotech companies. Over 20 presentations and case studies focusing on the discovery of stem cells in regenerative medicine, manufacturing innovations in clinical trials and bioprocessing methods in cell line development.

Tél.: [+441865248455];     Email.: g.alonso@oxfordglobal.co.uk

Stem Cell, Stem Cell Discovery, Stem Cell Bioprocessing, Bioprocessing, cell line development, clinical trials, regenerative medicine

Over 350 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

Over 40 presentations, case studies and panel discussions focusing on the key issues in cell line optimisation, 3D cell culture and bioprocessing technologies

4 interactive streams:

- Cell Line Development

- PART 1: Early Cell Culture & Cell Line Engineering

- PART 2: 3D Cell Culture Models & Applications

- Process Development: Upstream Bioprocessing and Analytics

- Cell Line Development: Late Stage Cell Line Development, Stability, Data & Assay Data Development

- Cell Culture and Downstream Bioprocessing

View Agenda: https://bit.ly/2s1Ng0J

For further information about the congress, please contact Guillaume Alonso at g.alonso@oxfordglobal.co.uk or visit the website https://bit.ly/2GF3jGh

Guillaume Alonso;     Tél.: [+441865248455];     Email.: g.alonso@oxfordglobal.co.uk

Cell Line Development, Cell Culture. Bioprocessing, Upstream Bioprocessing, Downstream Bioprocessing, Cell Line

Biologie moléculaire,    Cellules souches

20th Pharmacovigilance 2019 Conference provides the strongest context, background, updates, new developments, and future direction for regulations and guidance on safety, pharmacovigilance, and risk management strategies that cannot be found in any other meeting. The content of this event is developed by top experts from the biopharmaceutical industry and global regulatory agencies, and Virtue Insight will convene the best speakers from around the world to discuss the current challenges and issues that matter most to professionals working in the field.

Tél.: [+91 44 24762472];     Email.: kavitha@virtueinsight.co.in

Pharmacovigilance, DrugSafety, ProductSafety, DrugDevelopment, ClinicalSafety, patientsafety, RiskManagement, regulatoryaffairs

Over 600 delegates are expected to attend the SynGen Series UK, representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading global pharmaceutical organisations and biotech companies.

Tél.: [+441865248455];     Email.: d.dalby@oxfordglobal.co.uk

Digital PCR. NGS, Single Cell Analysis, Genome Editing, Synthetic Biology, DPCR, Cancer, Infectious Disease Diagnosis, Next Generation Sequencing & Clinical Diagnostics, Single Cell Analysis, PCR, QPCR, Oncology

Génomique et bio-informatique,    Cancérologie

ISOPT Clinical, Retina Chapter is the meeting for those who are interested in clinical research, those who wonder how drugs are developed, appreciate the opportunities and limitations of new technologies, the industry and those who would like to collaborate with it.Presentations and discussions will focus on: drugs and technologies that we own now and their best use in specific clinical situations, drugs and technologies that are in late phase development and their expected impact, defining and addressing the unmet medical needs that are still evident.

Tél.: [+972 3 517 5150 Ext. 609];     Email.: isopt@target-conferences.com

retina, Macula, Fovea, Retinal Diseases, ocular infection, Ocular Inflammation, Innovation in Ophthalmology, Ocular Drug Development, Drug delivery

Discover the critical factors for successful implementation and sustainability of Key Account Management (KAM) programmes in Pharma - Master an 8-step model for making the right strategic decisions, whilst promoting greater multi-functional working - Learn key insights and case-study examples to avoid typical pitfalls that have caused failures in the past.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [0086-411-84799609-826];     Email.: jessica@iddst-china.com

Breaking Drug Discovery Research, Smart Screening for Hits to Leads, Emerging Drug Targets, Immunotherapy, Informatics Frontier, Preclinical Evaluation, Bioprocessing of Biotherapy, Natural Products & TCM, Smart Drug Design, Major Disease INDs

Learn and anticipate the market access challenges in rare diseases – Know how to leverage patient-centric real world evidence to accelerate the patient and market access of innovative and potentially transformative Orphan Medicinal Products (OMPs) and Advanced Therapy Medicinal Products (ATMPs) – Acquire planning tools that maximise product value of OMPs and ATMPs from launch to loss of exclusivity.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Grasp the meaning, concepts, terminology, methodologies and research techniques of Real World Evidence (RWE) in the context of optimising Market Access - Know what each stakeholder type expects from RWE, which key data to use and how to develop a successful RWE study – Learn how to incorporate RWE into the product pre-launch process.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Peptide Drug Discovery: a Niche Area?

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Grasp the organizational implications of the different HTA outcomes in key European markets – Learn the different approaches and decision criteria used by major HTA bodies, as well as the critical success factors when preparing for HTA submissions – Know the reasons why outcomes and recommendations might vary, as well as the nuances of evaluating orphan drugs.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Be able to decide on the best deal type for products in R&D – Know what to include in CDAs, MTAs and term sheets – Learn how to prepare product information and how to find potential partners – Know how to calculate the value of your product and optimise the deal structure.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Pharma conference 2019 will have an intensive 2-day program with a wide range of topics covering pharmacy practice, pharmaceutical science, pharmacology, pharmacovigilance, and many other pharmaceutical developments. World-renowned speakers and eminent delegates across the globe attending the conference, to share their valuable presentation on the most recent and advanced techniques, developments, and the newest updates are the prominent features of the conference.

Tél.: [442088910774];     Email.: Pharma@pharmameet.org

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Spreadsheet Applications such as MS Excel are frequently used in 21 CFR 11 compliant environments, but they were not specifically designed for regulated environments and their development is not optimized for 21 CFR 11 compliance. However, the FDA expects that spreadsheets be compliant and lack of compliance can result in a warning letter. Consequently, validation of Excel Spreadsheet Applications is required as part of a 21 CFR 11 compliant environment.

Traininng.com LLC;     Tél.: [(510) 962-8903];     Email.: traininngdotcom@gmail.com

Learning destination for professionals courses, world class professionals trainings, professionals training courses

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

The day is aimed at medical and non-medical delegates who are new to assessing, authorising and prescribing SACT.

Conference Team;     Tél.: [02078082921];     Email.: conferenceteam@rmh.nhs.uk

Pharmaceutical Microbiology as an industry is projected to see significant advancements in the next five years. This forecast is largely attributed to rapid microbiology testing, which has accounted for $3.5 billion last year, while projected to reach nearly double at $6 billion by 2025, and an estimated CAGR of 8.3% leading up to 2025. At the very core of pharmaceutical microbiology is the accurate and reliable detection of microorganisms that would otherwise contaminate the pharmaceutical products manufactured. This demand for more rapid methods for detection and identification will be accompanied by equally important areas such as: contamination control strategies and environmental monitoring, process automation, and discussing updates to meet regulatory requirements.

Join us at SMi’s 9th Annual Pharmaceutical Microbiology Conference to explore novel and developing technologies that tackle the most pressing challenges and push innovation in world of pharmaceutical microbiology.

Tél.: [07800890224];     Email.: ssapal@smi-online.co.uk

Pharmaceutical Microbiology, Microbiology, Pharmaceuticals, Aseptic Technique, Sterility, Bioburden, Mycoplasma, Quality Control, Rapid Microbial Methods, Data Integrity, Risk Assessments, Environmental Monitoring

Génie biomédical,    Microtechnologie, nanotechnologie

Cambridge Healthech Institute

PepTalk delivers a wide scientific spectrum featuring case studies, unpublished data, breakthroughs & solutions that support and enhance biotherapeutic research, plus an exhibit hall featuring technology & service providers, and 150+ research posters

Cambridge Healthtech Institute;     Tél.: [7819725400];     Email.: chi@healthtech.com

antibodies, antibody therapeutics, antibody-drug conjugates, biologics, biotech, biotechnology, biotherapeutics, cell, gene therapy, life sciences, medical science, protein, protein aggregation, protein expression, science, the protein science week, bioengineering, bio engineering, bio-engineering, bioscience

Chemical biology is a scientific discipline that promises to apply the latest chemical approaches to interrogate complex biological systems and is, consequently, at the very heart of modern pharmacology. This conference will explore how recent advances in chemical biology are helping to expand the druggable proteome and enhance our understanding of disease biology .

EMBL Events;     Tél.: [+49 6221 387 8797];     Email.: events@embl.de

Drug discovery, chemical biology, genomics, DNA-sensing pathways, proteolysis targeting chimeras (PROTACs), targeted protein degradation, druggable proteome, druggable genome, phenotypic screens, chemical probes, chemogenomics, bioinformatics

Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

The ECI “Delivery of Nucleic Acid Therapeutics: Biology, Engineering and Development” conference will provide a forum for increasing our mechanistic understanding of the biological processes underpinning non-viral and viral delivery, including molecular and cellular biology, virology, in vivo pharmacology and toxicology, rational optimization strategies, targeting, formulation, bioengineering and process development solutions to scale-up and manufacturing, regulatory considerations and preclinical and clinical NAT programs.

Tél.: [212516760];     Email.: noel@engconfintl.org

nucleic acid RNA mRNA viral drug development vectors tropism virology NAT cargo ASO's Therapeutics

Learn how to design a digital marketing strategy for your brand, therapeutic area or company that integrates into the whole marketing mix – Grasp the full power and trends of all digital tactics in pharma – Learn how, and when, to select the appropriate tactics, optimise the mix and how to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Join us at our 3rd Annual Formulation & Drug Delivery USA Congress - Over 300 delegates - Over 55 case studies & Presentations - Six highly interactive streams

Tél.: [+441865248455];     Email.: g.alonso@oxfordglobal.co.uk

Formulation, Drug Delivery, Drug Development, Cell & Gene Therapy

In the light of this theme “Future breakthrough in Toxicology and Pharmacology for the better world”, Toxicology and Pharmacology Summit aims to provide a forum for international researchers and academicians from various areas of biology, chemistry, pharmacology, and medicine by providing one kind of platform for critical analysis of new designing, and to share latest cutting-edge research findings, most recent movements and latest upgrades inside the field of Pharmacology with explicit keynote lectures, plenary sessions, Poster competition, Young Researchers’ Forum (YRF), Workshops, Symposiums and Exhibitions from elite researchers, distinguished scientists and business delegates. It allows delegates to have issues addressed on Toxicology & Pharmacology by recognized global experts who are up to date with the latest developments in the field to a common forum and also exchange ideas makes us updated about the advancements and innovations in Toxicology and Pharmacology in a wide range.

Tél.: [1 631 303 3007];     Email.: toxicology.us@gmail.com

Medicine Development and Safety Testing, Therapeutic Drug Monitoring and Drug, Environmental and Occupational Toxicology, Developmental Pharmacology, Molecular and Biochemical Toxicology, Reproductive and Developmental Toxicology, Applied Pharmacology, Genetic Toxicology and Toxicity Testing, Product Development Toxicology, Industrial & Occupational Toxicology, Toxicological Pharmacovigilance, Toxicologic Pathology, Clinical Trials on different Diseases and Medical Devices, Toxicology Consulting, Genetic and Cellular Toxicology, Aquatic Toxicology, Toxicology Global Market, Toxicology Current Advances, Pharmacology and Drug Design, Pharmacological Testing, Toxicology Risk Assessment, Immunopharmacology and Immunotoxicology, Advances in Pharmacological Research, Market Analysis of Pharmacology, Biochemical pharmacology, Cardiovascular Pharmacology.

Learn the evidence-based concepts, models and techniques that work best to forecast the sales of pharmaceuticals – Know how to build Market Access into your forecasts – Learn to distinguish reliable from bad forecasts and how to forecast cost-effectively – Get practice with an Excel-based forecasting tool that integrates all the techniques taught.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

The rising tide of counterfeit medicines are turning into a serious concern around the world, and have progressively been showing up through the real pharmaceutical supply chain, including community and online drug stores.Counterfeit drugs are not only a global public health risk, but also harm the quality of the product, the integrity of the brand, the economy and even national security.We require both countrywide and industry-level participation, and in addition public and private sector coordinated effort, to identify and definitively battle counterfeiters.

Tél.: [02070960786];     Email.: info@corvusglobalevents.com

PharmaSecurityWorld, counterfeitdrugs, Anticounterfeiting, BrandProtection, drugsecuritySerialization, Traceability, SupplyChain, IP, PharmaSupplyChain, Packaging, BrandEnforcement, BrandIntegrity, Labelling, Printing, TrackAndTrace, DrugRegulatory, RFID, fakedrugs

Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn to design a digital innovation strategy for Medical Affairs – Grasp the full power and trends of the whole spectrum of digital tactics that affect physicians and patients – Learn how to optimise the mix of tactics and to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn and anticipate the market access challenges in rare diseases – Know how to leverage patient-centric real world evidence to accelerate the patient and market access of innovative and potentially transformative Orphan Medicinal Products (OMPs) and Advanced Therapy Medicinal Products (ATMPs) – Acquire planning tools that maximise product value of OMPs and ATMPs from launch to loss of exclusivity.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how medical affairs can enhance the commercial success of pharma brands with market insight generation, brand value definition, and HCP/patient engagement – Learn the critical success factors of a competitive medical affairs strategy and of an impactful tactical mix – Get familiar with the fundamentals of health economics and of leadership development.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Engineering Conferences International (ECI)

It is well known that the physical and chemical properties of the DS (API) have major impacts on the formulation and the Drug Product (DP) process. In any dosage form including solid, liquid and semi-solid, the Drug Substance (DS) or Active Pharmaceutical Ingredient (API) goes through a formulation process. This process to make the final drug product serves many purposes, but all with the goal of eventually delivering the active ingredient to the desired sites in the patients’ body in the most convenient way and to achieve optimal therapeutic effect.

Tél.: [2125146760];     Email.: noel@engconfintl.org

Role particle engineering process scaleup Pharmaceutical composite materials DS/DP interface integration DS (API)

Learn how to engage patients with multi-channel disease awareness / patient activation campaigns – Know how to support patients in their therapy with multi-stakeholder / multi-channel patient adherence programmes – Be able to measure success and impact on the critical success factors of a patient-centric organisation.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the drivers of patient health behaviours – Learn how to identify and interpret specific individual drivers of health behaviours – Understand the practical steps to design/enhance your support solutions in a way that delivers true personalisation and support for all stakeholders - Take your current patient/caregiver/HCP support solution(s) to the next level with insights from Professor John Weinman and Nathan O’Donnell.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the role of MSLs within the organisation – Gain business acumen by understanding how the MSL can optimally add value to both external and internal stakeholders – Know how strategic decisions determine MSL tactics – Learn how to successfully plan and implement typical MSL tactics, and how to assess their impact – Discuss and discover how to deal with issues that MSLs typically are confronted with.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Be able to decide on the best deal type for products in R&D – Know what to include in CDAs, MTAs and term sheets – Learn how to prepare product information and how to find potential partners – Know how to calculate the value of your product and optimise the deal structure.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to design a digital marketing strategy for your brand, therapeutic area or company that integrates into the whole marketing mix – Grasp the full power and trends of all digital tactics in pharma – Learn how, and when, to select the appropriate tactics, optimise the mix and how to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn and practice in role plays the whole armamentarium of winning strategies, tools, dos & don’ts, tricks & tips in each step of the pharma licensing negotiation process: planning – internal negotiations – making the first contact – term sheet assumptions – face-to-face meetings – resolving issues – contract closure.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Prepare for patent expiry with a winning LCM plan for established brands – Know which drivers of differentiation can be used – Learn where, when and how to compete in a generic world using late stage LCM strategies & tactics – Learn how to make portfolio management decisions for mature brands.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to analyse your brand’s market so that you discover all sales levers – Know how to determine priority segments and define a value positioning statement – Learn how to design the optimal mix of marketing tactics in both Red (highly competitive) & Blue (highly innovative) Ocean markets.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn the evidence-based concepts, models and techniques that work best to forecast the sales of pharmaceuticals – Know how to build Market Access into your forecasts – Learn to distinguish reliable from bad forecasts and how to forecast cost-effectively – Get practice with an Excel-based forecasting tool that integrates all the techniques taught.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand what HTA really means, the different types of HTAs across the EU and what can be expected from it – Learn the optimal HTA process and which criteria for assessment should be applied – Discover multiple solutions for optimising the quality of the evidence.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Master the critical success factors of a commercial drug launch: Selecting the right launch type – A structured roadmap – The critical market insights you need to gain in pre-launch phases – Identifying leverage points along the patient journey – Defining and prioritising customer segments - Designing the most effective omni-channel strategy and plan.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the language, the concepts and research techniques in pharmaceutical pricing – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+31887569555];     Email.: congress2020@ecnp.eu

brain disorder, health, neurology, pharma, mental disorder

Neurologie,    Psychiatrie

Learn to design a digital innovation strategy for Medical Affairs – Grasp the full power and trends of the whole spectrum of digital tactics that affect physicians and patients – Learn how to optimise the mix of tactics and to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to design a digital marketing strategy for your brand, therapeutic area or company that integrates into the whole marketing mix – Grasp the full power and trends of all digital tactics in pharma – Learn how, and when, to select the appropriate tactics, optimise the mix and how to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the role of MSLs within the organisation – Gain business acumen by understanding how the MSL can optimally add value to both external and internal stakeholders – Know how strategic decisions determine MSL tactics – Learn how to successfully plan and implement typical MSL tactics, and how to assess their impact – Discuss and discover how to deal with issues that MSLs typically are confronted with.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to engage patients with multi-channel disease awareness / patient activation campaigns – Know how to support patients in their therapy with multi-stakeholder / multi-channel patient adherence programmes – Be able to measure success and impact on the critical success factors of a patient-centric organisation.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn the evidence-based concepts, models and techniques that work best to forecast the sales of pharmaceuticals – Know how to build Market Access into your forecasts – Learn to distinguish reliable from bad forecasts and how to forecast cost-effectively – Get practice with an Excel-based forecasting tool that integrates all the techniques taught.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Biogate Scientific Center welcomes Vaccines Summit Ohio (VSOhio20) in Columbus, OH from October 05-07, 2020. VSOhio20 will cover a broad range of topics like animal models, clinical trials, big data, and analytics. The summit will bring together participants from around the globe, including high-level political decision-makers, health ministers, UN organizations, NGOs, academia representatives, renowned researchers and healthcare professionals, vaccine industry CEOs, celebrities and social media influencers who actively support vaccination.

Tél.: [+1 410 246 4289];     Email.: sachin@bsc.events

Vaccine Technology, Animal Models, Influenza Vaccines, Vaccine Safety Science, Regulatory Science, Clinical Evaluation, Nonclinical Development, Vaccine Hesitancy, Big data and Analytics

Master the critical success factors of a commercial drug launch: Selecting the right launch type – A structured roadmap – The critical market insights you need to gain in pre-launch phases – Identifying leverage points along the patient journey – Defining and prioritising customer segments - Designing the most effective omni-channel strategy and plan.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn and anticipate the market access challenges in rare diseases – Know how to leverage patient-centric real world evidence to accelerate the patient and market access of innovative and potentially transformative Orphan Medicinal Products (OMPs) and Advanced Therapy Medicinal Products (ATMPs) – Acquire planning tools that maximise product value of OMPs and ATMPs from launch to loss of exclusivity.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how medical affairs can enhance the commercial success of pharma brands with market insight generation, brand value definition, and HCP/patient engagement – Learn the critical success factors of a competitive medical affairs strategy and of an impactful tactical mix – Get familiar with the fundamentals of health economics and of leadership development.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the language, the concepts and research techniques in pharmaceutical pricing – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Prepare for patent expiry with a winning LCM plan for established brands – Know which drivers of differentiation can be used – Learn where, when and how to compete in a generic world using late stage LCM strategies & tactics – Learn how to make portfolio management decisions for mature brands.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand what HTA really means, the different types of HTAs across the EU and what can be expected from it – Learn the optimal HTA process and which criteria for assessment should be applied – Discover multiple solutions for optimising the quality of the evidence.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to engage patients with multi-channel disease awareness / patient activation campaigns – Know how to support patients in their therapy with multi-stakeholder / multi-channel patient adherence programmes – Be able to measure success and impact on the critical success factors of a patient-centric organisation.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to analyse your brand’s market so that you discover all sales levers – Know how to determine priority segments and define a value positioning statement – Learn how to design the optimal mix of marketing tactics in both Red (highly competitive) & Blue (highly innovative) Ocean markets.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the marketing principles that determine a pharmaceutical’s commercial success - Learn how your function can contribute to a pharma brand’s success in the new environment - Know how pharma marketers take strategic and tactical decisions - Gain ideas for cross-functional synergies that benefit a brand’s success.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn and practice in role plays the whole armamentarium of winning strategies, tools, dos & don’ts, tricks & tips in each step of the pharma licensing negotiation process: planning – internal negotiations – making the first contact – term sheet assumptions – face-to-face meetings – resolving issues – contract closure.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn and anticipate the market access challenges in rare diseases – Know how to leverage patient-centric real world evidence to accelerate the patient and market access of innovative and potentially transformative Orphan Medicinal Products (OMPs) and Advanced Therapy Medicinal Products (ATMPs) – Acquire planning tools that maximise product value of OMPs and ATMPs from launch to loss of exclusivity.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the drivers of patient health behaviours – Learn how to identify and interpret specific individual drivers of health behaviours – Understand the practical steps to design/enhance your support solutions in a way that delivers true personalisation and support for all stakeholders - Take your current patient/caregiver/HCP support solution(s) to the next level with insights from Professor John Weinman and Nathan O’Donnell.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the role of MSLs within the organisation – Gain business acumen by understanding how the MSL can optimally add value to both external and internal stakeholders – Know how strategic decisions determine MSL tactics – Learn how to successfully plan and implement typical MSL tactics, and how to assess their impact – Discuss and discover how to deal with issues that MSLs typically are confronted with.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Be able to decide on the best deal type for products in R&D – Know what to include in CDAs, MTAs and term sheets – Learn how to prepare product information and how to find potential partners – Know how to calculate the value of your product and optimise the deal structure.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how medical affairs can enhance the commercial success of pharma brands with market insight generation, brand value definition, and HCP/patient engagement – Learn the critical success factors of a competitive medical affairs strategy and of an impactful tactical mix – Get familiar with the fundamentals of health economics and of leadership development.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the language, the concepts and research techniques in pharmaceutical pricing – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn to design a digital innovation strategy for Medical Affairs – Grasp the full power and trends of the whole spectrum of digital tactics that affect physicians and patients – Learn how to optimise the mix of tactics and to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to design a digital marketing strategy for your brand, therapeutic area or company that integrates into the whole marketing mix – Grasp the full power and trends of all digital tactics in pharma – Learn how, and when, to select the appropriate tactics, optimise the mix and how to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Master the critical success factors of a commercial drug launch: Selecting the right launch type – A structured roadmap – The critical market insights you need to gain in pre-launch phases – Identifying leverage points along the patient journey – Defining and prioritising customer segments - Designing the most effective omni-channel strategy and plan.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn the evidence-based concepts, models and techniques that work best to forecast the sales of pharmaceuticals – Know how to build Market Access into your forecasts – Learn to distinguish reliable from bad forecasts and how to forecast cost-effectively – Get practice with an Excel-based forecasting tool that integrates all the techniques taught.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com